SCHEMBL14446129

SCHEMBL14446129

CCCCCCCCCCCCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)O[Si](C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13207638 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL13601435 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL25532062 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL12659590 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL14030480 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL12602194 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL14132460 1.00 TSHR (0.33) TSHRTHRB
SCHEMBL13026844 0.98
SCHEMBL12288169 0.98 TSHR (0.35) TSHRTHRB
SCHEMBL13701628 0.96 TSHR (0.33) TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230030989-A1 JUST SUNSCREEN POUCH PAC INNOVATIONS, LLC 2023-02-02 US claimed
EP-4683612-A1 COSMETIC COMPOSITIONS CONTAINING DECARBOXYLATED OLIGOPEPTIDE AND PYRACANTHA EXTRACT AND METHODS FOR TREATING LIPOFUSCIN ELC Management LLC (US) 2026-01-28 EP disclosed
US-12485086-B2 Cosmetic compositions and method of using the same ELC MANAGEMENT LLC 2025-12-02 US disclosed
CN-120114354-A Cosmetic product 株式会社资生堂 2025-06-10 CN disclosed
EP-4524207-A2 PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS ELC Management LLC (US) 2025-03-19 EP disclosed
US-12103903-B2 Photostabilizing compounds, compositions, and methods ELC MANAGEMENT LLC (US) 2024-10-01 US disclosed
WO-2024192747-A1 COSMETIC COMPOSITIONS CONTAINING DECARBOXYLATED OLIGOPEPTIDE AND PYRACANTHA EXTRACT AND METHODS FOR TREATING LIPOFUSCIN ELC MANAGEMENT LLC (US) 2024-09-26 WO disclosed
EP-4429632-A1 COSMETIC COMPOSITIONS AND METHOD OF USING THE SAME ELC Management LLC (US) 2024-09-18 EP disclosed
EP-4429465-A1 COMPOSITIONS COMPRISING TRPM8 AGONISTIC COOLING AGENTS Symrise AG (DE) 2024-09-18 EP disclosed
US-20240294468-A1 PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS ELC MAN LLC (US) 2024-09-05 US disclosed
EP-4167930-A1 METHOD FOR PRODUCING PERSONALIZED COSMETICS BASF SE (DE) 2023-04-26 EP disclosed
EP-4165011-A1 SOLUBIZATION OF RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES ELC Management LLC (US) 2023-04-19 EP disclosed
US-20230098934-A1 PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS ELC MAN LLC (US) 2023-03-30 US disclosed
US-11571674-B1 Environmentally biodegradable microcapsules TRUCAPSOL LLC (US) 2023-02-07 US disclosed
US-20230030989-A1 JUST SUNSCREEN POUCH PAC INNOVATIONS, LLC 2023-02-02 US disclosed
US-11530215-B2 Photostabilizing compounds, compositions, and methods ELC MAN LLC (US) 2022-12-20 US disclosed
US-11484485-B2 Photostabilizing compounds, compositions, and methods ELC MANAGEMENT LLC (US) 2022-11-01 US disclosed
US-11383003-B2 Water soluble farnesol analogs and their use KIMBERLY-CLARK WORLDWIDE, INC. (US) 2022-07-12 US disclosed
EP-3806815-B1 PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS ELC MAN LLC (US) 2022-06-01 EP disclosed
US-7241853-B2 Printing processes employing intermediate transfer with molten intermediate transfer materials XEROX CORPORATION (US) 2007-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12103903-B2 Photostabilizing compounds, compositions, and methods PPIC, PIN1, NISCH TSHR 4875/4885THRB 4876/4885
US-20240294468-A1 PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS PPIC, PIN1, NISCH TSHR 4875/4885THRB 4876/4885
US-11530215-B2 Photostabilizing compounds, compositions, and methods TYR, NISCH, PPOX TSHR 4858/4885THRB 4879/4885
US-12485086-B2 Cosmetic compositions and method of using the same CUTA, MMP13, LCT TSHR 4029/4885THRB 3935/4885
US-11484485-B2 Photostabilizing compounds, compositions, and methods PPIC, NISCH, ERCC1 TSHR 4878/4885THRB 4874/4885
US-20230098934-A1 PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND METHODS TYR, NISCH, PPOX TSHR 4858/4885THRB 4879/4885
US-11383003-B2 Water soluble farnesol analogs and their use FNTA, FNTB, GGPS1 TSHR 3427/4885THRB 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.